Survival effects of adjuvant gemcitabine plus S-1 chemotherapy on pancreatic carcinoma stratified by preoperative resectability status
Author:
Affiliation:
1. Department of Surgery, Institute of Biomedical and Health Sciences; Hiroshima University; Hiroshima Japan
Publisher
Wiley
Subject
Oncology,General Medicine,Surgery
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/jso.24156/fullpdf
Reference26 articles.
1. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma;Takada;Cancer,2002
2. A randomized phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for pancreatic cancer;Ueno;Br J Cancer,2009
3. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: The CONKO-001 randomized trial;Oettle;JAMA,2013
4. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial;Oettle;JAMA,2007
5. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine followed pancreatic cancer resection: A randomized controlled trial;Neoptolemos;JAMA,2010
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antitumor activity of genetically engineered NK-cells in non-hematological solid tumor: a comprehensive review;Frontiers in Immunology;2024-04-17
2. Δ3-tubulin impairs mitotic spindle morphology and increases nuclear size in pancreatic cancer cells;Medical Molecular Morphology;2023-11-06
3. Prognostic impact of pre- and postoperative tumor markers in patients with intrahepatic cholangiocarcinoma;Surgery Today;2023-06-21
4. Neoadjuvant therapy contributes to nodal downstaging of pancreatic cancer;Langenbeck's Archives of Surgery;2021-10-05
5. Preoperative risk factors for para-aortic lymph node positivity in pancreatic cancer;Pancreatology;2021-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3